BI 907828: A highly potent MDM2-p53 antagonist suitable for intermittent dose schedulesAndreas Gollner,Patrizia Sini,Dorothea Rudolph,Harald Weinstabl,Juergen Ramharter,Ulrike Weyer-Czernilofsky, Bojana Golubovic,Rolf Grempler, Alejandro Perez Pitarch, Reinhard Sailer,Darryl B. McConnell,Norbert KrautCANCER RESEARCH(2023)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要